P218 |
The
role of IL-4 and IFN-gamma as prognostic factors of major adverse
cardiac events in patients with ST-elevation myocardial infarction
assigned primary percutaneous coronary intervention |
|
M Osuch, B Szygula-Jurkiewicz, J Szkodzinski,
R Wojnicz, A Lekston, L Polonski, A Blazelonis & B Zubelewicz-Szkodzinska |
P219 |
Adiponectin
and resistin concentrations during oral glucose tolerance test
(OGTT) in insulinresistant subjects |
|
K Szosland, K Lewandowski, H Randeva & A
Lewinski |
P220 |
Effects
of IGF-II on glucose metabolism |
|
S Zachariah, A Brackenbridge & D Russell
Jones |
P221 |
Interleukin-6
and transforming growth factor beta-1 concentration in serum in
patients with coronary vessels restenosis |
|
AB Blazelonis, J Szkodzinski, W Romanowski,
A Danikiewicz, M Gasior, L Polonski, A Kaszuba, M Muc-Wierzgon & B
Zubelewicz-Szkodzinska |
P222 |
Immunosuppressive
effect of recombinant human erythropoietin |
|
A Vahdati, M Adib & S Kashfi |
P223 |
Low
dose dexamethasone does not alter serum adiponectin or resistin
concentrations |
|
KC Lewandowski, K Szosland & A Lewinski |
P224 |
Interleukin-6
and TNF-alpha in hemodialysis patients: association with obesity
and metabolic syndrome |
|
Z Rasic, G Perunicic, Z Gluvic, J Tica & M
Pavicevic |
P225 |
VEGF
and sVCAM in patients with adrenal gland tumors |
|
TA Britvin, NE Kushlinsky, IA Kazantseva,
MA Sivtsova & AP Kalinin |
P226 |
Prolactin
deficiency is independently associated with reduced IGF-I status
in severely GHD adults |
|
A Mukherjee, WDJ Ryder, A Jostel & SM
Shalet |
P227 |
GH/IGF-I
axis and haematological alterations in anorexia nervosa |
|
N Polli & F Cavagnini |
P228 |
Selected
hormones serum levels in dependence on BMI and sex |
|
M Tajtáková, Z Semanová,
D Petrás ¢ová, J Petrovic¡ová & M
Pytliak |
P229 |
Abnormalities
of humoral immunity with reduced immunogenicity to pneumococcal
vaccine in panhypopituitarism |
|
A Mukherjee, M Helbert, JRE Davis & SM
Shalet |
P230 |
Lack
of influence of an IGF-I gene polymorphism on circulating IGF-I
levels in severely GHD adults |
|
JAMJL Janssen, A Mukherjee, HK Gleeson, S
Lamberts & SM Shalet |
P231 |
Serum
TGF-beta-1 levels in non-alcoholic steatohepatitis |
|
S Yener, B Akinci, F Bayraktar, T Demir,
M Akarsu, MA Özcan, M Yalcin, L Kebapcilar, A Comlekci & S
Yesil |
P232 |
Subclinical
hypothyroidism could be regarded as a benign condition in oxidative
stress but not in atherosclerosis |
|
L Kebapcilar, B Akinci, F Bayraktar, A Comlekci,
A Solak, T Demir, S Yener, T Kume, A Ozkaya & S Yesil |
P233 |
Low
TGF-beta-1 levels in idiopathic male osteoporosis |
|
B Akinci, F Bayraktar, A Saklamaz, T Demir,
S Yener, A Comlekci, MA Ozcan, L Kebapcilar, F Yuksel & S Yesil |
P234 |
Possible
predictive value of IGF-II mRNA expression in breast cancer (BC) |
|
CG Giani, EG Giustarini, PF Fierabracci,
DC Campani & MEL Lippman |
P235 |
IGF-II
protein expression in breast cancer. Relationship with the most
important predictive parameters in breast malignancy |
|
EG Giustarini, AP Pinchera, DC Campani, PF
Fierabracci, KC Cullen & CG Giani |
P236 |
The
effect of growth hormone replacement on the diurnal and ultradian
dynamics of ghrelin and leptin in adult growth hormone deficiency |
|
F Joseph, G Brabant, A Ahmad, B Durham, WD
Fraser & JP Vora |
P237 |
Growth
hormone receptor extracellular domain linked to glycophosphatidyl
inositol (GHR-GPI); a potential growth hormone receptor antagonist |
|
CE Bowles, I Wilkinson, N Gavalas, P Watson,
D Watts & R Ross |
P238 |
The
depot specific expression of NPY in human adipose tissue and its
upregulation under hyperinsulinaemic conditions in isolated human
adipocytes |
|
K Kos, AL Harte, P Gupta, P O'Hare, PG McTernan & S
Kumar |
P239 |
The
role of BMPs in the establishment of zona glomerulosa in the adrenal
gland |
|
A Bakmanidis & PJ King |
P240 |
Anosmin-1:
a novel cofactor for fibroblast growth factor receptor-1 |
|
Y Hu, S Kim, S Cadman, S Guimond, J Turnbull & P
Bouloux |
P241 |
Effect
of growth hormone deficiency in adults on insulin action and gene
expression of selected adipokines in subcutaneous adipose tissue |
|
A Penesova, M Skopkova, M Pura, M Vlcek,
Z Radikova, I Vorzakova, M Tajtakova, P Vanuga, V Belan, J Koska,
J Payer, I Klimes & D Gasperikova |
P242 |
Soluble
interleukin 2 receptor is elevated in sera of women with Graves'
disease and has relation to serum free thyroxine and thyroid volume |
|
J Jiskra, M Antosova, E Potlukova, Z Lacinova,
H Mareckova, P Sandova, D Smutek & Z Limanova |
P243 |
Molecular
mechanisms of idiopathic muscle hypertrophy in humans |
|
AM Solomon, EP Hoffman, SD Ghimbovschi, Z
Wang, RW Orrell, G Goldspink, SD Harridge & PMG Bouloux |
P244 |
CD4
T-cell count improves during sustained IGF-I response following
low dose growth hormone therapy in HIV-infected patients on stable
antiretroviral regimens. A pilot study |
|
O Andersen, BR Hansen, A Flyvbjerg, S Madsbad,
H Ørskov, JO Nielsen, J Iversen & SB Haugaard |
P245 |
The
differential influence of specific plant lectins on insulin and
IGFs binding to solubilised placental membrane IGF and insulin
receptors |
|
R Masnikosa, I Baricevic & O Nedic |
P246 |
GH
and GH antagonist B2036 effect on the immune system |
|
M Maamra, F Perna, A Colao, R Pivonello,
S Zappacosta, RJM Ross & G Matarese |
P247 |
IGF-I
modulates HIF-1alpha and HIF-2alpha in Kaposi sarcoma |
|
SB Catrina, IR Botusan, A Rantanen, AI Catrina,
P Pyakurel, M Axelson, P Biberfeld, L Poellinger & K Brismar |
P248 |
Proinflammatory
cytokine gene expression shows intrinsic circadian oscillation
in peripheral cells |
|
A McMaster, J Lebiecki, A Loudon, R Donn & DW
Ray |
P249 |
Plasma
interleukin 1a in patients with polycystic ovary syndrome - relation
to insulin resistance |
|
I Kowalska, M Straczkowski, A Nikolajuk,
A Kozlowska, M Karczewska-Kupczewska, A Adamska, S Wolczynski,
I Kinalska & M Gorska |
P250 |
Expression
of functional toll-like receptors in adipocytes |
|
KM Oeff & SR Bornstein |
